Abstract
Visseral leyshmanioz (kala-azar) – Leishmania infantum deb nomlangan bir hujayrali (Protozoa) hayvonlar tomonidan keltirilib chiqariladigan kasallik turi hisoblanadi. Bu kasallikni tashxislashingi bugungi kunda bir necha usullari mavjud bo‘lib ular quyidagilardir: Mikroskopiya – kasallangan odamlarning ichki a’zolaridan (suyak ko‘migi, taloq, limfa tugunlari va jigar) namunalar mikrosok ostida teksiriladi va tashxis qo‘yiladi, Serodiagnostik usullar – atigen antitana bog‘lanishini aniqlash usuli bo‘lib bugungi kunda bir necha xil rivojlangan usullari bor, va PZR – polimer zanjir reaksiyalari orqali tegishli parazitning DNKsi mavjud ekanligini aniqlaydigan usul hisoblanadi. Shulardan Serologik tashxis usullari eng qulay usul xisoblanib bunda bemorning qon namunasini tekshirish orqali tegishli natijani olish imkoniyati mavjud xisoblanadi
References
1. World Health Organization. (2023). Leishmaniasis fact sheet. Geneva: World Health Organization. Available at: https://www.who.int/news-room/fact-sheets/detail/leishmaniasis
2. Alvar, J., Aparicio, P., Aseffa, A., Den Boer, M., Cañavate, C., Dedet, J. P., Gradoni, L., Ter Horst, R., López-Vélez, R., & Moreno, J. (2008). The relationship between leishmaniasis and AIDS: the second 10 years. Clinical Microbiology Reviews, 21(2), 334–359. https://doi.org/10.1128/CMR.00061-07
3. Altman, D. G., & Bland, J. M. (1994). Diagnostic tests 1: sensitivity and specificity. BMJ, 308, 1552. https://doi.org/10.1136/bmj.308.6943.1552
4. Boelaert, M., Verdonck, K., Menten, J., Sunyoto, T., van Griensven, J., Chappuis, F., & Rijal, S. (2014). Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease. BMJ, 348, g1952. https://doi.org/10.1136/bmj.g1952
5. Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., & STARD Group. (2015). STARD 2015: An updated list of essential items for reporting diagnostic accuracy studies. BMJ, 351, h5527. https://doi.org/10.1136/bmj.h5527
6. Chappuis, F., Rijal, S., Soto, A., Menten, J., & Boelaert, M. (2006). A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ, 333, 723. https://doi.org/10.1136/bmj.38917.503056.7C
7. Chappuis, F., Sundar, S., Hailu, A., Ghalib, H., Rijal, S., Peeling, R. W., Alvar, J., & Boelaert, M. (2007). Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nature Reviews Microbiology, 5(11), 873–882. https://doi.org/10.1038/nrmicro1748
8. Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
9. Sundar, S., & Rai, M. (2002). Laboratory diagnosis of visceral leishmaniasis. Clinical and Diagnostic Laboratory Immunology, 9(5), 951–958. https://doi.org/10.1128/CDLI.9.5.951-958.2002
This work is licensed under a Creative Commons Attribution 4.0 International License.